The invention relates to 3apos; construction method of mRNA sequencing library
By sequencing the 3' end of mRNA, the library construction steps of RNA-seq technology are simplified, and the problems of high quality requirements and complex steps in the existing technology are solved, and low-cost and efficient RNA sequencing is achieved, which is compatible with low quality Samples and improve sequencing accuracy and efficiency.
Patent Information
- Application Number
- CN202411134244.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-26
AI Technical Summary
The existing RNA-seq technology faces high sample quality requirements, complex steps and high cost under the requirements of high throughput and high accuracy, and is particularly difficult to be compatible with low-quality samples, which limits its application in scientific research and clinical diagnosis.
Using the method of sequencing the 3' end of mRNA, reverse transcriptase and reverse transcription primers were constructed through the reverse transcription system, and poly(T)VN primers of Nextera Read2 sequence and barcode sequence were combined to simplify the library construction steps, and Klenow was used after degrading RNA. Fragment DNA polymerase was double-stranded synthesis and PCR library amplified by illumina Nextera transposase to generate double-stranded DNA products with complete linker structure.
The library construction steps are simplified, compatible with low-quality samples, reduce sequencing costs, improve technical consistency, sequencing accuracy and efficiency among samples, and reduce the complexity of subsequent data analysis.
Smart Images

Figure CN119020457A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of molecular biology, and in particular relates to a method for constructing a 3'mRNA sequencing library. Background Art
[0002] Over the past decade, RNA-seq has become an essential tool for analyzing differential gene expression and differential splicing of mRNAs across the transcriptome. It has been applied to studying various aspects of RNA biology, including gene expression, translation (translatome), RNA structure (structurome), regulatory RNAs, RNA epigenetics, and RNA dynamics. With the advancement of next-generation sequencing technologies, RNA-seq has continued to advance, and its application areas, such as spatial transcriptomics, have also expanded. Coupled with the recent application of long-read sequencing and direct RNA-seq technologies, as well as the further integration of computational tools for data analysis, innovations in RNA-seq have enabled a more comprehensive understanding of RNA biology.
[0003] The conventional RNA-seq sequencing process typically includes the following steps: mRNA enrichment or ribosomal RNA removal (this should be selected based on RNA quality and research direction; for degraded RNA samples, such as those with RIN <7, ribosomal RNA removal should be selected), RNA fragmentation, first-strand cDNA synthesis, second-strand cDNA synthesis, A-tailing and adapter addition, and library amplification. Of course, there will be purification steps in between. Conventional RNA-seq typically requires a total RNA input of 1ng-2μg. This often presents challenges in achieving high throughput and high precision, limiting its application in scientific research and clinical diagnosis.
[0004] 3' mRNA sequencing methods, which sequence the 3' end of mRNA molecules, can effectively simplify library construction, reduce sequencing costs, and improve sequencing accuracy and efficiency. Therefore, developing an improved 3' end mRNA sequencing method has important scientific research and clinical application value. Summary of the Invention
[0005] The present invention aims to solve one of the technical problems existing in the prior art to at least a certain extent. To this end, the present invention provides a method for constructing a 3'mRNA sequencing library.
[0006] According to one aspect of the present invention, the method for constructing the 3' mRNA sequencing library comprises the following steps:
[0007] S102: Provide target RNA.
[0008] S104: Constructing a reverse transcription system to reverse transcribe the target RNA to obtain an mRNA-cDNA hybrid chain, wherein the reverse transcription system includes a reverse transcriptase and a reverse transcription primer, and the reverse transcription primer includes a poly(T)VN primer adapter with a Nextera Read2 sequence and a barcode sequence.
[0009] The poly(T) sequence binds to the poly(A) tail of mRNA, ensuring specific reverse transcription of the mRNA. The VN sequence adds random bases (V is any of A, C, or G, and N is any base) to the end of the poly(T) sequence, increasing the specificity and efficiency of primer binding. Reverse transcriptase extends along the mRNA template from the 3' end to the 5' end, synthesizing cDNA. During this process, the Nextera Read2 sequence and barcode sequence of the reverse transcription primer are introduced to the 3' end of the cDNA, facilitating subsequent library construction and sample differentiation.
[0010] S106: Degrading the RNA in the mRNA-cDNA hybrid chain to obtain a single-stranded cDNA chain with a specific linker sequence at the 3' end; after the reaction is completed, high-temperature treatment at 95°C inactivates the reverse transcriptase and degrades the template RNA, releasing the cDNA from the RNA-DNA hybrid chain.
[0011] S108: Construct a double-stranded synthesis system, add Klenow Fragment DNA polymerase and double-stranded synthesis random primers, convert the single-stranded cDNA into double-stranded DNA, and have adapter sequences at both ends for library amplification, wherein the double-stranded synthesis random primers contain Nextera Read2 sequence and random sequence, bind to random sites on the single-stranded cDNA, and initiate double-stranded synthesis.
[0012] To convert single-stranded cDNA into double-stranded DNA (ds-DNA), double-stranded synthesis random primers (containing the NexteraRead2 sequence and a random sequence) are used. These random primers play the following roles in the double-stranded synthesis process:
[0013] Double-stranded synthesis random primers bind randomly to various locations within the single-stranded cDNA through their random sequence moieties. Primer binding provides an initiation point for Klenow Fragment DNA Polymerase, initiating second-strand cDNA synthesis. The Nextera Read2 sequence contained in the primers is incorporated into the 5' end of the cDNA fragment during synthesis, ensuring that the final double-stranded DNA synthesized has specific adapter sequences at both ends.
[0014] Klenow Fragment DNA Polymerase is a DNA polymerase that possesses efficient DNA synthesis but lacks 5'→3' exonuclease activity. Guided by a random primer for second-strand synthesis, Klenow polymerase synthesizes second-strand cDNA along a single-stranded cDNA template, starting from the 3' end of the primer. Through continuous random primer binding and extension by Klenow polymerase, the entire single-stranded cDNA is ultimately converted to double-stranded DNA.
[0015] S110: Recover the double-stranded synthesis product and remove excess oligonucleotides, nucleotides, salts, and enzyme components.
[0016] S112: Using the recovered double-stranded synthetic product as a template, PCR library amplification is performed using an index-containing primer pair for Illumina Nextera transposase library construction to generate a double-stranded DNA product for sequencing, with complete linker structures at both ends that can be used for Illumina sequencing.
[0017] The method of the present invention has the following beneficial effects:
[0018] Simplified library construction steps: By sequencing the 3' end of the mRNA, the steps of polyT magnetic bead enrichment or ribosomal RNA cleanup, mRNA shearing, and adapter ligation required for traditional full-length transcript sequencing library construction are eliminated, significantly simplifying the library construction process, shortening operation time, and reducing the use of reagents and consumables. Compatible with low-quality samples: Traditional full-length transcript sequencing library construction usually relies on polyT magnetic beads to enrich mRNA, requiring the mRNA molecules in the sample to be as complete as possible. Any breakage of the mRNA molecule will prevent its 5' end from being captured, affecting the sequencing coverage of the 5' end of the transcript, making the FPKM, RPKM, or TPM results based on transcript length correction inaccurate, thereby reducing the quality of the sequencing results. This method does not require the mRNA to remain intact, only needs to capture a few hundred bases at the 3' end, which is compatible with low-quality samples and expands the application range of RNA sequencing.
[0019] Improve technical consistency between samples: By simplifying the library construction steps and combining samples for second-strand synthesis after reverse transcription, the sources of sample differences during the operation are reduced, and the differences between samples in the same batch are reduced.
[0020] Reduce sequencing costs: Since only the 3' end of the mRNA is sequenced, the read length required for sequencing can be reduced, thereby reducing sequencing costs.
[0021] Improve sequencing accuracy and efficiency: The 3'-end sequencing method can more accurately reflect gene expression levels, eliminating the need to calibrate the impact of transcript length on sequencing depth through methods such as FPKM and RPKM. In theory, the number of sequences read for each gene is proportional to the number of its mRNA molecules, greatly simplifying the subsequent data analysis process and improving sequencing accuracy and efficiency. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] The drawings described herein are used to provide a further understanding of the present invention and constitute a part of this application. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the drawings:
[0023] Figure 1 Shown is a technical principle diagram provided according to an embodiment of the present invention;
[0024] Figure 2 Shown is an agarose gel electrophoresis diagram of the amplified library provided in an embodiment of the present invention;
[0025] Figure 3 Shown is an Agilent Bioanalyzer length distribution diagram of a library provided according to an embodiment of the present invention;
[0026] Figure 4 The figure shows the quality results of double-end sequencing of the library provided in accordance with an embodiment of the present invention;
[0027] Figure 5 The relationship between the number of detected genes and sequencing reads provided by an embodiment of the present invention is shown;
[0028] Figure 6 The relationship between the number of statistically significantly up-regulated and down-regulated genes detected and the sequencing read counts provided by the embodiments of the present invention is shown;
[0029] Figure 7 A correlation diagram of the fold change of differentially expressed genes detected by the method provided by an embodiment of the present invention and the traditional RNA sequencing method is shown. DETAILED DESCRIPTION
[0030] Although the present invention can be implemented in many different forms, what is disclosed here is its specific illustrative embodiment that proves the principle of the present invention. It should be emphasized that the present invention is not limited to the specific embodiment illustrated. In addition, any section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described.
[0031] Unless otherwise defined herein, the scientific and technical terms used in conjunction with the present invention will have the meanings commonly understood by those of ordinary skill in the art. In addition, unless the context requires otherwise, terms in the singular shall include the plural and terms in the plural shall include the singular.
[0032] Generally, terms relating to, and techniques of, cell and tissue culture, molecular biology, immunology, microbiology, genetics, and protein and nucleic acid chemistry and hybridization described herein are those well known and commonly used in the art. Unless otherwise indicated, the methods and techniques of the present invention are generally performed according to conventional methods well known in the art.
[0033] The following examples are provided to facilitate a clearer understanding of the present invention for those skilled in the art. It should be noted that the following examples do not limit the scope of the present invention and are provided for illustrative purposes only. Unless otherwise specified, the raw materials, reagents, and devices mentioned in the following examples are commercially available or obtained by known methods.
[0034] Example RNA sequencing of human synovial fibroblasts stimulated by tumor necrosis factor α (TNF-α)
[0035] Preparation of cell samples
[0036] Digest human synovial fibroblasts from a cell culture flask using trypsin. After digestion, transfer the cell suspension to a sterile tube and collect the cells by centrifugation (1000 rpm for 5 minutes). Resuspend the cells in culture medium and count the cells to ensure an appropriate cell concentration. Adjust the cell concentration to a seeding density suitable for a 6-well plate, 1 × 10^5 cells per well. Add an appropriate amount of the cell suspension to each of the four wells of the 6-well plate.
[0037] Add TNF-α to a final concentration of 1 ng / mL to two wells (labeled TNF1 and TNF2). Add the appropriate amount of TNF-α solution directly to the culture medium to achieve the desired concentration. Add an equal volume of PBS to two other wells (labeled CONT1 and CONT2) as controls.
[0038] The 6-well plate was returned to the cell culture incubator and cultured for another 3 days (72 hours).
[0039] Extraction of total cellular RNA
[0040] The culture medium was discarded, the cells were rinsed with PBS, the PBS was aspirated, 0.5 mL of Trizol was added to each well, and the tubes were transferred to 1.5 mL centrifuge tubes. 0.1 mL of chloroform was added to each tube, and the tubes were vortexed for 30 seconds. The tubes were allowed to stand on ice for 3 minutes for preliminary stratification. The tubes were centrifuged at 18,000 g for 10 minutes at 4°C. The upper aqueous phase was transferred to a new 1.5 mL centrifuge tube, an equal amount of isopropanol was added and mixed, the tubes were allowed to stand on ice for 30 minutes, and the tubes were centrifuged at 18,000 g for 10 minutes at 4°C. When RNA precipitate was visible, the waste liquid was aspirated, 1 mL of 75% alcohol was added, the pellet was vortexed to resuspend, and the pellet was centrifuged at 18,000 g for 10 minutes at 4°C. The waste liquid was aspirated, 1 mL of 75% alcohol was added, the pellet was vortexed to resuspend, and the pellet was centrifuged at 18,000 g for 10 minutes at 4°C. The waste liquid was aspirated, the tubes were opened and allowed to stand until the alcohol evaporated, and nuclease-free water was added to dissolve the RNA pellet. The RNA concentration was measured using a Nanodrop microspectrophotometer.
[0041] Reverse transcription of total RNA using sample-specific barcoded reverse transcription primers
[0042] Prepare 4 PCR tubes, add 100 ng of total RNA to each tube, add 1 μL of different reverse transcription primers (20 μM) to each sample, record the primer number used for each sample, and add water to 12.5 μL.
[0043] The primers used were any four from the table below.
[0044]
[0045] Incubate the reaction at 65°C for 5 minutes on a PCR instrument. Remove the reaction tube from the PCR instrument and return it to room temperature. Then add 4 μL 5× reverse transcription buffer, 2 μL 10mM dNTP mix, and 1 μL M-MLV BeyoRT TM II M-MLV Reverse Transcriptase (RNaseH-) (D7160S), 0.5 μL RNAse inhibitor was pipetted and mixed thoroughly.
[0046] The reaction system is 20 μL, 100 ng RNA, 1 μM NtRd2-T18VN, 200 U BeyoRT TM II M-MLV reverse transcriptase (RNase H-), 20U RNAse inhibitor, 1mM dNTP each, 42℃ for 15min, 95℃ for 15min. Figure 1 shown.
[0047] Double-strand synthesis reaction
[0048] Take the reaction tube out of the PCR instrument, pipette 10 μL of each sample into a new PCR tube, mix thoroughly by pipetting, and then take 20 μL into another new PCR tube and add 1.5 μL of water, 2 μL Double-stranded Synthesize primer Mix (62.5 μM), 1 μL 5× reverse transcription buffer, 0.5 μL Klenow Fragment Exo-(2.5U), pipette to mix, react at 25°C for 15 min, react at 37°C for 45 min, add 30 μL SPRI magnetic beads (1.2× volume) to the reaction tube, let it stand at room temperature for 5 min, let it stand on the magnetic stand until the magnetic beads adhere, aspirate and discard the supernatant, add 200 μL 80% ethanol, let it stand for 30 s, aspirate and discard the supernatant, repeat the above washing steps 2 times, a total of 3 times, let it stand in the open for about 5 min, evaporate the ethanol, remove the PCR tube from the magnetic stand, resuspend the magnetic beads in 25 μL water, let it stand for 5 min, let it stand on the magnetic stand until the magnetic beads adhere, transfer 23 μL of eluate to a new PCR tube for library amplification.
[0049] PCR library amplification
[0050] Add 1 μL each of i5 / i7 adapter primers (30 μM) to 23 μL of product; select one from N501-N508 as the i5 adapter primer, and select one from N701-N712 as the i7 adapter primer, with the final concentration of each adapter primer being 600 nM.
[0051] Add 25 μL Ultra TM II The Master Mix was reacted according to the following procedure.
[0052]
[0053] Library quality control
[0054] After the reaction is complete, take 5 μL and run it on a 2% agarose gel (using a narrow-pore comb) to check the quality of the amplified product. A successful reaction has the following characteristics: Figure 2 Electrophoretic characteristics shown.
[0055] The library was tested using Bioanalyzer. A successful library had the following characteristics: Figure 3 Features shown.
[0056] Library sequencing
[0057] The library was sequenced using Illumina Novaseq X Plus in PE150 mode (paired-end sequencing, 150 bp per end).
[0058] Sequencing data sample splitting
[0059] Use idemux (github: Lexogen-Tools / idemux) to split the fastq format sequencing data downloaded from the machine, and distinguish each sample in the mixed library based on the barcode sequence carried by the reverse transcription primer in Read2.
[0060] Sequencing data quality control
[0061] The quality of the split data was assessed using the fastqc tool. Figure 4 As shown, the sequencing data from this method is high-quality on the Read1 side, but the quality of the data on the Read2 side drops sharply after reading the polyA tail. Therefore, Read2 data can only be used for barcode deconvolution. Read1 data quality control was performed using the cutadapt tool to remove adapters and low-quality sequences.
[0062] Sequencing data aligned to the human reference genome
[0063] The quality-controlled Read1 sequences were aligned to the human reference genome using the STAR aligner tool.
[0064]
[0065]
[0066] Gene coverage saturation analysis
[0067] like Figure 5 As shown in the figure, by randomly selecting up to 10 million reads per sample for analysis, the number of gene detections under different sequencing data amounts was detected. It was found that about 12,000 genes could be detected under saturation conditions, and sequencing 4-6 million reads per sample was sufficient to achieve a sufficiently high sequencing saturation.
[0068] Saturation analysis of differential gene detection
[0069] like Figure 6 As shown in the figure, by randomly selecting up to 10 million reads per sample for analysis, the number of differentially expressed genes between the CONT and TNF groups was determined at different sequencing data volumes. It was found that as the sequencing data volume increased, the number of significantly up-regulated and down-regulated differentially expressed genes increased.
[0070] Correlation analysis of differentially expressed genes detected by this method and traditional RNA sequencing
[0071] like Figure 7As shown in the figure, the same batch of RNA samples were subjected to traditional RNA sequencing and compared with this method (10 million reads of each sample were randomly sampled for analysis). It was found that the detected differentially expressed genes and their fold changes were highly correlated with this method, and R 2 The value reaches about 0.85.
[0072] The foregoing description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Those skilled in the art will readily appreciate that various modifications and variations of the present invention are possible. Any modifications, equivalent substitutions, or improvements made within the spirit and principles of the present invention are intended to be within the scope of protection of the present invention.
Claims
1. A method for constructing a 3'mRNA sequencing library, characterized in that: The following steps are involved: Provide target RNA; Constructing a reverse transcription system to reverse transcribe the target RNA to obtain an mRNA-cDNA hybrid chain; Degrading RNA in the mRNA-cDNA hybrid chain to obtain a single-stranded cDNA with a specific linker sequence at the 3' end; Constructing a double-stranded synthesis system, adding Klenow Fragment DNA polymerase and double-stranded synthesis random primers to convert the single-stranded cDNA into double-stranded DNA; The double-stranded synthesis product is recovered and used as a template for PCR library amplification to generate a double-stranded DNA product for sequencing.
2. The construction method according to claim 1, characterized in that: Recovery of double-stranded synthesis products includes: The double-stranded synthesis product is recovered by a magnetic bead method to obtain DNA products within a specific length range.
3. The construction method according to claim 1, characterized in that: Amplifying the PCR library using the double-stranded synthetic product as a template comprises: The double-stranded synthetic product is used as a template and an index-containing primer pair for library construction of Illumina Nextera transposase is used to perform PCR library amplification to generate a double-stranded DNA product for sequencing with complete adapter structures at both ends that can be used for Illumina sequencing.
4. The construction method according to any one of claims 1 to 3, characterized in that: The reverse transcription system comprises a reverse transcriptase and a reverse transcription primer, and the reverse transcription primer comprises a poly(T)VN primer adapter with a Nextera Read2 sequence and a barcode sequence.
5. The construction method according to any one of claims 1 to 3, characterized in that: The double-stranded synthesis random primer comprises a Nextera Read2 sequence and a random sequence, and is bound to a random position of the single-stranded cDNA to initiate double-stranded synthesis.
Citation Information
Patent Citations
Method for carrying out molecule bar code labeling on mRNA of a lot of tissues and cell samples, library construction method and sequencing method
CN107502607A
Reverse transcription primer for hybrid library construction of mRNA 3'terminal and application thereof
CN109055519A
Method for rapid construction of RNA 3' terminal gene expression library
CN110257479A
Construction method of 3 'mRNA sequencing library
CN116103368A
